New Stock News | Shenzhen Mindray Bio-Medical Electronics (300760.SZ) responds to rumors of a second IPO in Hong Kong: Official information released by the company should be considered accurate.

On July 23rd, there were market reports stating that medical equipment manufacturer Shenzhen Mindray Bio-Medical Electronics (300760.SZ) is considering a second listing in Hong Kong, with an expected fundraising amount of at least $1 billion USD (approximately HK$7.8 billion). Shenzhen Mindray Bio-Medical Electronics has been in discussions with potential advisors regarding the possible share offering. In response to this, Shenzhen Mindray Bio-Medical Electronics stated to refer to official announcements for accurate information. As a global leading provider of medical equipment and solutions, Shenzhen Mindray Bio-Medical Electronics has the most comprehensive product line in the domestic industry, with its products such as monitors, anesthesia machines, ventilators, defibrillators, hematology analyzers, ultrasound machines, etc. ranking in the top three globally. The company's medical ecosystem continues to deepen in clinical settings, focusing on critical care units. In 2024, it launched the Qiyuan critical care model, with plans to expand its application to other departments such as emergency, anesthesia, imaging, and laboratory departments in the future. The company aims to fully integrate data intelligence in areas such as diagnostic assistance, report generation and review, clinical case and knowledge retrieval, teaching, and research.